The abstract is read at the publisher; the summary is JClub's.
A scalable suspension-culture protocol generates UB-like organoids from hiPSC-derived nephron organoids, producing up to 2000 organoids in seven days and enabling cyst assays in PKD2-deficient cultures.
- Why it matters: ADPKD has limited therapies despite being common, and existing organoid models need large-scale, drug-discovery-ready cyst systems with measurable cyst phenotypes.
- What they did: Day 12 nephron organoids from wild-type and PKD2-deficient hiPSC lines were dissociated and grown in UB-propagating suspension conditions, then cyst number and diameter were quantified from brightfield images over ten days.
- The result: PKD2-deficient UB organoids initiate cystogenesis within seven days and reach very high cyst-forming efficiency by about 20 days, respond to JQ1 and QNZ, and a TLR4 antagonist (M1) reduces cyst size.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.